The plasma levels of thrombin activatable fibrinolysis inhibitor in patients with primary hypothyroidism before and after treatment

Basit Öğe Kaydı
dc.contributor.authorErmantas, N.
dc.contributor.authorGuldiken, S.
dc.contributor.authorDemir, M.
dc.contributor.authorTugrul, A.
dc.date.accessioned2024-06-12T11:23:18Z
dc.date.available2024-06-12T11:23:18Z
dc.date.issued2009
dc.departmentTrakya Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpage1008en_US
dc.identifier.issn1538-7933
dc.identifier.issn1538-7836
dc.identifier.startpage1008en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/26367
dc.identifier.volume7en_US
dc.identifier.wosWOS:001050017305282en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofJournal Of Thrombosis And Haemostasisen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleThe plasma levels of thrombin activatable fibrinolysis inhibitor in patients with primary hypothyroidism before and after treatmenten_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu